122 341

Cited 7 times in

Histone deacetylase inhibition enhances adenoviral vector transduction in inner ear tissue.

Authors
Taura, A; Taura, K; Choung, YH; Masuda, M; Pak, K; Chavez, E; Ryan, AF
Citation
Neuroscience, 166(4):1185-1193, 2010
Journal Title
Neuroscience
ISSN
0306-45221873-7544
Abstract
Adenovirus vectors (AdVs) are efficient tools for gene therapy in many tissues. Several studies have demonstrated successful transgene transduction with AdVs in the inner ear of rodents [Kawamoto K, Ishimoto SI, Minoda R, Brough DE, Raphael Y (2003) J Neurosci 23:4395-4400]. However, toxicity of AdVs [Morral N, O'Neal WK, Rice K, Leland MM, Piedra PA, Aguilar-Cordova E, Carey KD, Beaudet AL, Langston C (2002) Hum Gene Ther 13:143-154.] or lack of tropism to important cell types such as hair cells [Shou J, Zheng JL, Gao WQ (2003) Mol Cell Neurosci 23:169-179] appears to limit their experimental and potential clinical utility. Histone deacetylase inhibitors (HDIs) are known to enhance AdV-mediated transgene expression in various organs [Dion LD, Goldsmith KT, Tang DC, Engler JA, Yoshida M, Garver RI Jr (1997) Virology 231:201-209], but their effects in the inner ear have not been documented. We investigated the ability of one HDI, trichostatin A (TSA), to enhance AdV-mediated transgene expression in inner ear tissue. We cultured neonatal rat macular and cochlear explants, and transduced them with an AdV encoding green fluorescent protein (Ad-GFP) under the control of a constitutive promoter for 24 h. In the absence of TSA, GFP expression was limited, and very few hair cells were transduced. TSA did not enhance transduction when applied at the onset of Ad-GFP transduction. However, administration of TSA during or just after Ad-GFP application increased GFP expression in supporting cells approximately fourfold. Moreover, vestibular hair cell transduction was enhanced approximately sixfold, and that of inner hair cells by more than 17-fold. These results suggest that TSA increases AdV-mediated transgene expression in the inner ear, including the successful transduction of hair cells. HDIs, some of which are currently under clinical trials (Sandor et al., 2002), could be useful tools in overcoming current limitations of gene therapy in the inner ear using Ad-GFP.
MeSH terms
Adenoviridae/geneticsAnimalsAnimals, NewbornCells, CulturedDrug Delivery Systems/methodsGene Expression Regulation/geneticsGene Therapy/*methodsGenetic Vectors/*geneticsGreen Fluorescent Proteins/geneticsHair Cells, Auditory/drug effects/*metabolismHair Cells, Vestibular/drug effects/metabolismHearing Loss, Sensorineural/metabolism/physiopathology/*therapyHistone Deacetylase Inhibitors/*pharmacology/therapeutic useHistone Deacetylases/drug effects/metabolismHydroxamic Acids/pharmacology/therapeutic useLabyrinth Supporting Cells/drug effects/metabolismNerve Growth Factors/pharmacology/therapeutic useOrgan Culture TechniquesPromoter Regions, Genetic/geneticsRatsRats, WistarTransduction, Genetic/*methodsTransgenes/genetics
DOI
10.1016/j.neuroscience.2009.12.064
PMID
20060033
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Otolaryngology
AJOU Authors
정, 연훈
Full Text Link
Files in This Item:
1185-1193.pdfDownload
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse